Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to 5.35%.

  • Select Medical Holdings' EBIT Margin rose 10300.0% to 5.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.46%, marking a year-over-year increase of 40100.0%. This contributed to the annual value of 5.17% for FY2024, which is 3600.0% down from last year.
  • Latest data reveals that Select Medical Holdings reported EBIT Margin of 5.35% as of Q3 2025, which was up 10300.0% from 6.46% recorded in Q2 2025.
  • Select Medical Holdings' 5-year EBIT Margin high stood at 120.13% for Q4 2022, and its period low was 14.23% during Q4 2023.
  • Its 5-year average for EBIT Margin is 13.12%, with a median of 7.63% in 2022.
  • Per our database at Business Quant, Select Medical Holdings' EBIT Margin soared by 1151600bps in 2022 and then tumbled by -1343600bps in 2023.
  • Quarter analysis of 5 years shows Select Medical Holdings' EBIT Margin stood at 4.97% in 2021, then surged by 2317bps to 120.13% in 2022, then plummeted by -112bps to 14.23% in 2023, then surged by 111bps to 1.61% in 2024, then surged by 233bps to 5.35% in 2025.
  • Its last three reported values are 5.35% in Q3 2025, 6.46% for Q2 2025, and 8.33% during Q1 2025.